Manistee Therapeutics, Inc. — Form D
Manistee Therapeutics, Inc. of CONCORD, MA, a company, filed a Form D exempt-offering notice with the SEC on 2021-07-26. The offering totals $9.5M, of which $9.5M was reported sold. Industry: Other.
Offering
- Filed: 2021-07-26
- Form: D
- Accession: 0001567619-21-013956
- Industry: Other
- Exemptions: 06b
- Total offering: $9.5M
- Amount sold: $9.5M
- Investors: 6
- Date of first sale: 2021-07-13
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-407718
Issuer
- Name: Manistee Therapeutics, Inc.
- CIK: 0001874367
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 84 BARNES HILL ROAD, CONCORD, MA, 01742
- Phone: 617-538-7105
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Robert L Bratzler, Ph.D. | Director | Concord, MA |
| Stephen L Bruso | Director | Concord, MA |
| Bradford J Shingleton, M.D | Director | Concord, MA |
| Robert L Bratzler, Ph.D. | Executive Officer | Concord, MA |
| Bradford J Shingleton, M.D | Executive Officer | Concord, MA |
More